FDA Advisers Recommend Approving Monthly Injectable Buprenorphine for Opioid Use Disorder (FREE)

By Amy Orciari Herman Edited by Susan Sadoughi, MD An FDA advisory panel has voted 18 to 1 in favor of approving a once-monthly …
Source: Physician's First Watch current issue - Category: Primary Care Source Type: news
More News: Primary Care